Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy
NCT: NCT04782869 · COMPLETED
Brief Summary
This project aims to conduct a pilot study based on the targeting of the epileptogenic zone previously localized very precisely by stereoelectroencephalography (SEEG). SEEG is used as part of the pre-surgical assessment. It consists, thanks to the intracerebral implantation of electrodes in the brain of patients, to perform an intracerebral electrophysiological recording and thus to precisely explore the epileptogenic regions. In order to study the neuromodulatory and therapeutic effects of tDCS on epileptic brains, non-invasive techniques for measuring electrophysiological brain activity such as magnetoencephalography (MEG) and high-resolution electroencephalography (HR EEG) will be used. Finally, since epilepsy is considered to be a disorder of brain functional networks associated with disturbed brain connectivity, the effects of tDCS on cortical excitability by studying the variations in functional connectivity induced by stimulation will be studied.
Frequently Asked Questions
What is Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy?
Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy is a clinical trial registered under NCT04782869. Current status: COMPLETED.
What is the status of NCT04782869?
The current status of NCT04782869 (Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy) is: COMPLETED.
When did Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy start?
Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy started on 2021-03-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.